Page 53 - Read Online

Page 14 of 14 Cui et al. Microbiome Res Rep. 2025;4:31 https://dx.doi.org/10.20517/mrr.2025.25

81. Cui X, Chen J, Yang Y. Administration of selenomethionine in combination with serine benefits diabetes via gut microbiota. Front
Microbiol. 2022;13:1007814. DOI PubMed PMC
82. Su X, Chen S, Liu J, et al. Composition of gut microbiota and non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Obes Rev. 2024;25:e13646. DOI PubMed
83. Zai W, Chen W, Liu H, Ju D. Therapeutic opportunities of IL-22 in non-alcoholic fatty liver disease: from molecular mechanisms to
clinical applications. Biomedicines. 2021;9:1912. DOI PubMed PMC
84. Maestri M, Santopaolo F, Pompili M, Gasbarrini A, Ponziani FR. Gut microbiota modulation in patients with non-alcoholic fatty liver
disease: effects of current treatments and future strategies. Front Nutr. 2023;10:1110536. DOI PubMed PMC
85. Pezzino S, Sofia M, Mazzone C, et al. Gut microbiome in the progression of NAFLD, NASH and cirrhosis, and its connection with
biotics: a bibliometric study using dimensions scientific research database. Biology. 2023;12:662. DOI PubMed PMC
86. Liu J, Wu A, Cai J, She ZG, Li H. The contribution of the gut-liver axis to the immune signaling pathway of NAFLD. Front Immunol.
2022;13:968799. DOI PubMed PMC
87. Alveirinho M, Freitas P, Faleiro ML. Role of gut microbiota in metabolic syndrome: a review of recent evidence. Porto Biomed J.
2020;5:e105. DOI PubMed PMC
88. Qureshi W, Dar MA, Rather MY. New therapy for metabolic syndrome: gut microbiome supplementation. World J Diabetes.
2024;15:1833-6. DOI PubMed PMC
89. Li J, Zhao F, Wang Y, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5:14. DOI
PubMed PMC
90. Nakai M, Ribeiro RV, Stevens BR, et al. Essential hypertension is associated with changes in gut microbial metabolic pathways: a
multisite analysis of ambulatory blood pressure. Hypertension. 2021;78:804-15. DOI PubMed
91. Li C, Cheng D, Ren H, Zhang T. Unraveling the gut microbiota’s role in PCOS: a new frontier in metabolic health. Front Endocrinol.
2025;16:1529703. DOI PubMed PMC
92. Senthilkumar H, Arumugam M. Gut microbiota: a hidden player in polycystic ovary syndrome. J Transl Med. 2025;23:443. DOI
PubMed PMC
93. da Silva TR, Marchesan LB, Rampelotto PH, et al. Gut microbiota and gut-derived metabolites are altered and associated with dietary
intake in women with polycystic ovary syndrome. J Ovarian Res. 2024;17:232. DOI PubMed PMC